DRG Fingertip insights
보험 플랜, 정책 제한, PBM, 의료 제공자 등 마켓 액세스 의사결정에 필요한 데이터와 인사이트를 제공합니다.
Formulary Advantages in Oral Oncology Drugs: Health plans respond to generic entry, base formulary decisions on survival data
Private and Medicare plans will continue their receptiveness to oral oncology therapies over the next five years, but anticipated increases in coinsurance rates and copays will shift more of the cost…
Formulary Advantages in Therapies for Type II Diabetes: Crowding among anti-diabetic agents necessitates brand differentiation
Type 2 diabetes is a leading cause of cardiovascular disease, blindness, renal failure and neurologic dysfunction in the United States. Current epidemiologic studies estimate that nearly 24 million Am…